According to the research report titled ‘Mice Model Market Size By Mice Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application, By Use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 - 2026’, available with Market Study Report, global mice model market is touted to record a healthy growth rate through 2026.
 

Growing burden of various chronic diseases and rising inclination towards personalized medicines are the major propellers for global mice model industry growth. Besides, advancements in gene editing tools along with escalating demand for humanized mouse models especially in cancer research are enhancing the industry progression.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2419657/
 

For the uninitiated, mice model is commonly utilized in medical research as their genome is about 99% identical to human genome. The animal’s small size and exceptional genetic toolset makes it a cost-effective model. It holds vast potential in drug development and medical research as numerous identified bottlenecks are yet to be solved.
 

Speaking of the factors hindering industry expansion, ongoing development of alternative methods for animal testing, intensifying opposition on mice testing by various organizations, and strict regulations & guidelines are major challenges for businesses.
 

Based on type, global mice model market size from hybrid segment was valued USD 1,309 million in 2019 and is projected to register 6.9% CAGR through 2026. Higher survival rate and strong immunity against sickness are the characteristics favoring the use of hybrid mice in R&D activities.
 

In terms of application spectrum, academic segment surpassed USD 145 million valuation in 2019 and is set to record 7.9% CAGR through 2026. This can be ascribed to widespread utilization of mice models by educational institutions for studying biological behavior.
 

Considering the end-user scope, organizations segment accounted for USD 2,179 million in 2019 and is touted to expand at 6.6% CAGR over the analysis period, creditable to increasing initiatives supporting the use of mice models in medical research undertaken by healthy organizations.
 

From a geographical perspective, Middle East & Africa mice model industry was appraised USD 21.2 million in 2019 and is anticipated to record an appreciable CAGR of 5% over 2020-2026. Increasing research activities for development of novel drugs and therapeutic solutions due to surging cases of chronic diseases in MEA is stimulating the regional market expansion.
 

Prominent players in the industry are The Jackson Laboratory, TransViragen Inc., Hera BioLabs, GenOway S.A., Janvier Labs, Envigo, Taconic Biosciences Inc., and Charles River Laboratories Intl. Inc.